Correlation of F-18-FDG PET/CT assessments with disease activity and markers of inflammation in patients with early rheumatoid arthritis following the initiation of combination therapy with triple oral antirheumatic drugs

: Roivainen A, Hautaniemi S, Mottonen T, Nuutila P, Oikonen V, Parkkola R, Pricop L, Ress R, Seneca N, Seppanen M, Yli-Kerttula T

Publisher: SPRINGER

: 2013

: European Journal of Nuclear Medicine and Molecular Imaging

: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

: EUR J NUCL MED MOL I

: 3

: 40

: 3

: 403

: 410

: 8

: 1619-7070

DOI: https://doi.org/10.1007/s00259-012-2282-x

F-18-FDG PET/CT findings after 2 and 4 weeks of triple combination oral DMARD therapy correlated with treatment efficacy and clinical outcome in patients with early RA. F-18-FDG PET/CT may help predict the therapeutic response to novel drug treatments.